Pharmaceutical Capsules

• Dosage
• 40 MG

• Dosage Guidelines
• As per doctor suggestion

• Drug Type
• General Medicines

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 3*10 Box (30 tablets)

• Physical Form
• Capsules

• Storage Instructions
• Dry place

• Dosage Guidelines
• As per doctor suggestion

• Drug Type
• General Medicines

• Origin of Medicine
• India

• Pacakaging (Quantity Per Box)
• 10*10 Capsules

• Physical Form
• Capsules

• Storage Instructions
• Dry place

• Dosage
• 70 mg per capsule

• Dosage Form
• Capsule, hard

• Dosage Guidelines
• For oral use, as prescribed by healthcare provider

• Drug Type
• Other, Prescription Only Medicine

• Function
• Other, Central Nervous System Stimulant

• Indication
• Treatment of ADHD

• Ingredients
• Elvanse 70mg hard capsules contain lisdexamfetamine dimesylate and are the maximum daily licensed strength used to treat attention deficit hyperactivity disorder (ADHD) ADHD in Children: Used for children aged 6 years and older when other treatments, such as methylphenidate, do not work well enough.ADHD in Adults: Used for adults who had ADHD symptoms when they were children.Off-License Use: Sometimes prescribed off-license to treat narcolepsy and reduce severe daytime sleepiness

• Life Span
• See packaging for expiry date

• Origin of Medicine
• Manufactured by Takeda Pharmaceuticals

• Pacakaging (Quantity Per Box)
• 28 capsules

• Physical Form
• Other, Hard Capsules

• Quantity
• 28 capsules per bottle

• Recommended For
• Attention Deficit Hyperactivity Disorder (ADHD)

• Salt Composition
• Lisdexamfetamine dimesylate

• Storage Instructions
• Store below 25C, protect from light and moisture

• Suitable For
• Other, Adults and children as prescribed

• Dosage
• 1,800 mg daratumumab and 30,000 Units hyaluronidase-fihj per 15 mL

• Dosage Form
• Injection

• Dosage Guidelines
• Administer subcutaneous injection over 3 to 5 minutes

• Drug Type
• Other, Prescription only (Rx)

• Function
• Other, Monoclonal antibody for treatment of multiple myeloma

• Indication
• Multiple myeloma

• Ingredients
• Active ingredient: Daratumumab, a monoclonal antibody.Target: Binds to the CD38 protein found on abnormal white blood cells.Action: Signals your immune system to destroy the cancer cells

• Life Span
• Single-dose, discard unused portion

• Origin of Medicine
• Janssen

• Pacakaging (Quantity Per Box)
• Single vial per box

• Packaging Type
• Vial

• Physical Form
• Other, Injection

• Quantity
• One 15 mL vial

• Recommended For
• Adults with multiple myeloma

• Salt Composition
• Daratumumab 1,800 mg and Hyaluronidase-fihj 30,000 Units

• Storage Instructions
• Store as directed by manufacturer; discard unused portion

• Suitable For
• Other, Subcutaneous administration

• Dosage
• 15 mg per vial; to be reconstituted for intravenous use as per prescribing information

• Dosage Form
• Lyophilized powder for solution for injection

• Dosage Guidelines
• Administer as directed by a physician experienced in the management of ophthalmic conditions. Not intended for self-administration.

• Drug Type
• Other, Prescription drug

• Function
• Other, Photosensitizer used in photodynamic therapy

• Indication
• Choroidal neovascularization, mainly secondary to age-related macular degeneration

• Ingredients
• Visudyne (verteporfin) 15 mg is a light-activated prescription injection used with non-thermal laser therapy to treat abnormal, leaking blood vessels in the eye Treats wet age-related macular degeneration (AMD) with classic subfoveal choroidal neovascularization.Treats subfoveal choroidal neovascularization caused by pathological myopia or ocular histoplasmosis.Works as a photosensitizer that accumulates in new eye blood vessels and is activated by a specific laser wavelength to destroy abnormal tissue without harming surrounding retina layers

• Life Span
• Check expiration date on package; typically ranges from 18 to 24 months from manufacturing

• Origin of Medicine
• Imported/Pharmaceutical (Manufactured by Novartis)

• Pacakaging (Quantity Per Box)
• 1 vial per box

• Packaging Type
• Glass vial with carton packaging

• Physical Form
• Liquid

• Quantity
• 15 mg per vial

• Recommended For
• Treatment of predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia, or presumed ocular histoplasmosis

• Salt Composition
• Verteporfin 15 mg

• Storage Instructions
• Store at 2C to 8C (Refrigerate, do not freeze). Protect from light.

• Suitable For
• Adults